FIB-4 and ELF score are two well-validated biomarkers that assess the risk for liver fibrosis in patients with MASLD
As a weight loss doctor, I often receive questions from patients about the different types of weight loss medications available and how they compare to each other
Those who took semaglutide lost, on average, around 15 percent of their body weight roughly six times that of the placebo group
Summary Semaglutide reduces appetite by activating GLP-1 receptors in brain satiety centers, a mechanism that, in trials, has been associated with an average weight loss of 14.9% over 68 weeks
Ethereal Aesthetics Program: Guiding Your Journey Our specialized program at Ethereal Aesthetics in Vancouver, Washington, is designed to support healthy weight management through a combination of Semaglutide (an innovative anti-obesity medication), and nutrition and exercise counseling to help shift the paradigm of how we think about the way we care for our bodies in a holistic and healthy way
these factors make GLP-1 RAs an alternative initial treatment option, with or without metformin based on glycemic needs, in T2DM patients with indicators of high-risk or established heart failure (HF) or CKD who cannot tolerate an SGLT2 inhibitor